Atlas Trials

Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

Clinical trial NCT07427953 · COMPLETED

Trial details

NCT number
NCT07427953
Sponsor
Institute of Oncology Ljubljana
Status
COMPLETED
Study type
OBSERVATIONAL
Malignant MelanomaDrug-Induced Retinopathy
Start date
2023-01-01
Primary completion
2025-01-31
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.